Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2009

Open Access 01-12-2009 | Case report

Delivery of a baby with severe combined immunodeficiency at 31 weeks gestation following an extreme preterm prelabour spontaneous rupture of the membranes: a case report

Authors: Sally J Watkinson, Christopher CT Lee, Christopher V Steer

Published in: Journal of Medical Case Reports | Issue 1/2009

Login to get access

Abstract

Introduction

If left untreated, severe combined immunodeficiency can lead to an acute susceptibility to infection. The intrauterine environment is sterile until the amniotic membranes rupture. The vaginal flora then ascends into the genital tract, thus increasing the risk of chorioamnionitis. An extremely premature and prolonged membrane rupture is associated with a dismal prognosis for an immunocompetent preterm fetus. There are no case reports to date that detail the outcome of an immunocompromised preterm baby following prolonged rupture of membranes.

Case presentation

We present the case of a 32-year-old Indian woman who delivered a 31-week gestational baby who had a severe combined immunodeficiency following premature prelabour prolonged rupture of the membranes at the 14th week of gestation.

Conclusion

Extreme preterm prelabour spontaneous rupture of membranes in an underlying condition of severe combined immunodeficiency does not necessarily lead to an unfavourable outcome.
Literature
1.
go back to reference Lin Y, Liang Z, Chen J, Zeng Y: TLR3-involved modulation of pregnancy tolerance in double-stranded RNA-stimulated NOD/SCID mice. J Immunol. 2006, 176: 4147-4154.CrossRefPubMed Lin Y, Liang Z, Chen J, Zeng Y: TLR3-involved modulation of pregnancy tolerance in double-stranded RNA-stimulated NOD/SCID mice. J Immunol. 2006, 176: 4147-4154.CrossRefPubMed
2.
go back to reference Mercer B, Milluzzi C, Collin M: Periviable birth at 20 to 26 weeks of gestation: proximate causes, previous obstetric history and recurrence risk. Am J Obstet Gynecol. 2005, 193 (3 Pt 2): 1175-1180. 10.1016/j.ajog.2005.05.040.CrossRefPubMed Mercer B, Milluzzi C, Collin M: Periviable birth at 20 to 26 weeks of gestation: proximate causes, previous obstetric history and recurrence risk. Am J Obstet Gynecol. 2005, 193 (3 Pt 2): 1175-1180. 10.1016/j.ajog.2005.05.040.CrossRefPubMed
3.
go back to reference Palacio M, Cobo T, Figueras F, Gómez O, Coll O, Cararach V, Gratacós E: Previable rupture of membranes: effect of amniotic fluid on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2008, 138 (2): 158-163. 10.1016/j.ejogrb.2007.08.014.CrossRefPubMed Palacio M, Cobo T, Figueras F, Gómez O, Coll O, Cararach V, Gratacós E: Previable rupture of membranes: effect of amniotic fluid on pregnancy outcome. Eur J Obstet Gynecol Reprod Biol. 2008, 138 (2): 158-163. 10.1016/j.ejogrb.2007.08.014.CrossRefPubMed
4.
go back to reference Kenyon S, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group: Broad spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. The Lancet. 2001, 358 (9276): 156-CrossRef Kenyon S, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group: Broad spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. The Lancet. 2001, 358 (9276): 156-CrossRef
5.
go back to reference Kenyon S, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group: Broad spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. The Lancet. 2001, 357 (9261): 989-994. 10.1016/S0140-6736(00)04234-3.CrossRef Kenyon S, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group: Broad spectrum antibiotics for spontaneous preterm labour: the ORACLE II randomised trial. The Lancet. 2001, 357 (9261): 989-994. 10.1016/S0140-6736(00)04234-3.CrossRef
6.
go back to reference Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, Rabello YA, Meis PJ, Moawad AH, Iams JD, Van Dorsten JP, Paul RH, Bottoms SF, Merenstein G, Thom EA, Roberts JM, McNellis D: Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial by the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA. 1997, 278 (12): 989-995. 10.1001/jama.278.12.989.CrossRefPubMed Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, Rabello YA, Meis PJ, Moawad AH, Iams JD, Van Dorsten JP, Paul RH, Bottoms SF, Merenstein G, Thom EA, Roberts JM, McNellis D: Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes: a randomized controlled trial by the National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA. 1997, 278 (12): 989-995. 10.1001/jama.278.12.989.CrossRefPubMed
Metadata
Title
Delivery of a baby with severe combined immunodeficiency at 31 weeks gestation following an extreme preterm prelabour spontaneous rupture of the membranes: a case report
Authors
Sally J Watkinson
Christopher CT Lee
Christopher V Steer
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2009
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/1752-1947-3-118

Other articles of this Issue 1/2009

Journal of Medical Case Reports 1/2009 Go to the issue